PBL fights on in AFT Pascomer battle

The court allowed PBL a 35% share of all future profits from Pascomer sales.(Image: Unsplash)
PBL Solutions is appealing part of a high court judgment that found substantially in its favour in its stoush with AFT Pharmaceuticals over the so-called “orphan” (commercially undeveloped) drug Pascomer.The court found in favour of PBL, which is a 35% shareholder in AFT Orphan Pharmaceuticals (AFTO), in relation to its claim that AFT should have given AFTO the opportunity to pursue the development of the orphan drug Pascomer.Instead, AFT developed the drug on its own behalf. PBL claimed it had done the work to identify the com...
Subscribe to BusinessDesk
Stay informed on business, government and financial developments across New Zealand.
- Deeply researched, twice-edited and fact-checked news
- Annual subscribers also receive a complimentary subscription to The Wall Street Journal
- Personalised email news alerts, plus gift up to 5 stories a month to non-subscribers
You can cancel anytime with two clicks, an email or a phone call.
Find out more.
We are serious about journalism.
Already a Subscriber ? Sign in here.
{{ registerForm.errors.get('form') }}
We had trouble validating your card. It's possible your card provider is preventing us from charging the card. Please contact your card provider or customer support.
{{ cardForm.errors.get('card') }}
{{ registerForm.errors.get('plan') }}
{{ __(plans[index].name) | capitalize }}
{{ plans[index].attributes.old_price | currency }}
{{ plans[index].price | currency }}
All subscriptions auto renew but are easy to cancel.
Tax: {{ taxAmount(selectedPlan) | currency }}
Total Price Including Tax: {{ priceWithTax(selectedPlan) | currency }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerSeat ? '/ '+ spark.seatName : '' }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerTeam ? '/ '+ __('teams.team') : '' }} / {{ __(selectedPlan.interval) | capitalize }}
Total Price Including Tax: {{ priceWithTax(selectedPlan) | currency }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerSeat ? '/ '+ spark.seatName : '' }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerTeam ? '/ '+ __('teams.team') : '' }} / {{ __(selectedPlan.interval) | capitalize }}
{{ registerForm.errors.get('email') }}
Not convinced yet?
Subscribe to our free 7am Headlines newsletter.
A quick summary of everything BusinessDesk has published in the previous 24 hours. No BusinessDesk
subscription needed.